Gene-based factor VIIa prevents bleeding episodes in animals with hemophilia
(PHYSorg.com Biology)

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in animals may set the stage for a new therapy for a subset of patients with hemophilia who now develop antibodies to the standard maintenance treatment and then require on-demand `bypass` therapy.